Mayinglong Pharmaceutical Group Co., Ltd. Class ASSE: 600993

Announcement on Obtaining Notice of Approval for Drug Clinical Trial

· Issued by Mayinglong Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Notice of Approval for Drug Clinical Trial

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment